drugset / Trial / NCT01555931
Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding
Phase 4
Completed
61 enrolled
University of North Carolina, Chapel Hill
Society of Family Planning · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This will be a randomized clinical trial of 190 women aged 18-45 who plan to breastfeed their infant for at least 6 months and desire to use the LNG-IUS as their primary contraceptive method postpartum. The investigators will compare the frequency of breastfeeding among women receiving the levonorgestrel-releasing intrauterine system (LNG-IUS) immediately after vaginal delivery compared to 4-8 weeks later. The investigators hypothesize there will be no difference in breastfeeding prevalence between the two groups.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | Other |
Indications
No indication recorded.